Publications by authors named "Thomas Dayspring"

Claim this Profile
I
Inadequate Response to PCSK9 Inhibitors.
Tia Bimal, Tanesh Ayyalu, Maya S Safarova, Sean Donahoe, Courtney Davila, Thomas Dayspring

JACC Case Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development.
Szilard Voros, Aruna T Bansal, Michael R Barnes, Jagat Narula, Pal Maurovich-Horvat, Thomas Dayspring

Front Cardiovasc Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
James A Simon, Ayman Al-Hendy, David F Archer, Kurt T Barnhart, Linda D Bradley, Thomas Dayspring

Obstet Gynecol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudohypertriglyceridemia-Raising clinical awareness.
James M Backes, Thomas Dayspring, Patrick M Moriarty

J Clin Lipidol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
Eric J Brandt, Lane B Benes, Linda Lee, Thomas D Dayspring, Matthew Sorrentino

J Cardiovasc Pharmacol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients.
Thomas D Dayspring, Stephen A Varvel, Leila Ghaedi, Dawn L Thiselton, James Bruton

J Clin Lipidol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population.
Elliott Wolin, Justin White, James V Pottala, Maciek Sasinowski, Tara Dall, Thomas D Dayspring

J Clin Lipidol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice.
Stephen A Varvel, Thomas D Dayspring, Yvette Edmonds, Dawn L Thiselton, Leila Ghaedi

J Clin Lipidol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertriglyceridaemia unresponsive to multiple treatments.
James M Backes, Thomas D Dayspring, Daniel M Hoefner, Patrick M Moriarty

BMJ Case Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein(a) mass: a massively misunderstood metric.
Joseph P McConnell, Philip A Guadagno, Thomas D Dayspring, Daniel M Hoefner, Dawn L Thiselton

J Clin Lipidol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.
Philip A Guadagno, Erin G Summers Bellin, William S Harris, Thomas D Dayspring, Daniel M Hoefner

Clin Chim Acta· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels?
William S Harris, James V Pottala, Dawn L Thiselton, Stephen A Varvel, Alison M Baedke, Thomas D Dayspring

J Cardiovasc Transl Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omega-3 fatty acids and cardiovascular disease: new developments and applications.
William S Harris, Thomas D Dayspring, Terrance J Moran

Postgrad Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudohypertriglyceridemia: two cases of probable glycerol kinase deficiency.
James M Backes, Thomas Dayspring, Thomas Mieras, Patrick M Moriarty

J Clin Lipidol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudohypertriglyceridemia--verifying the hypertriglyceridemic patient.
James M Backes, Thomas Dayspring, Patrick M Moriarty

J Clin Lipidol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ezetimibe therapy: mechanism of action and clinical update.
Binh An P Phan, Thomas D Dayspring, Peter P Toth

Vasc Health Risk Manag· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Hector Malave, Manuel Castro, Jaime Burkle, Szilard Voros, Thomas Dayspring

Am J Cardiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety evaluation of rosuvastatin.
Peter P Toth, Thomas D Dayspring

Expert Opin Drug Saf· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters.
Thomas D Dayspring

Int J Womens Health· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of triglycerides on lipid and lipoprotein biology in women.
Thomas D Dayspring, Gregory Pokrywka

Gend Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images, lipoproteins, drugs, and atherothrombotic events.
Thomas Dayspring

Menopause· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.
Peter P Toth, Thomas D Dayspring, Gregory S Pokrywka

Curr Atheroscler Rep· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-density lipoproteins: emerging knowledge.
Thomas Dayspring

J Cardiometab Syndr· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
Thomas Dayspring, Gregory Pokrywka

Curr Atheroscler Rep· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia.
Thomas Dayspring, Yongming Qu, Cheryl Keech

Metabolism· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis